logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Monica Van Der Vieren

This inventor holds 10 USPTO granted patents. Top assignees: Icos Corporation, Other. Active years: 1995-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monica Van Der Vieren. Retrieved from https://idiyas.com/inventor/monica-van-der-vieren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 82(Granted Patents)


Location History:

  • Snohomish, WA (US) (2002)
  • Seattle, WA (US) (1995 - 2003)

Company Filing History:

goldMedal9 out of 164 
 
Icos Corporation
 patents
silverMedal1 out of 834,570 
Other
 patents

Years Active: 1995-2003

Loading Chart...
10 patents (USPTO):Explore Patents
1. 6620915 - Monoclonal antibodies specific for integrin &agr;-d subunit (2003-09-16),
2. 6432404 - Methods of inhibiting locomotor damage following spinal cord injury with &agr; D-specific antibodies (2002-08-13),
3. 6251395 - Methods of inhibiting inflammation at the site of a central nervous system injury with alphaD-specific antibodies (2001-06-26),
4. 5837478 - Method of identifying modulators of binding between and VCAM-1 (1998-11-17),
5. 5831029 - Human .beta.2 integrin .alpha. subunit (1998-11-03),
6. 5817515 - Human B2 integrin alpha subunit antibodies (1998-10-06),
7. 5766850 - Human .beta.2 integrin .alpha. subunit (1998-06-16),
8. 5728533 - Human .beta..sub.2 integrin .alpha.subunit (1998-03-17),
9. 5470953 - Human .beta..sub.2 integrin .alpha. subunit (1995-11-28),
10. 5437958 - Human .beta..sub.2 integrin .alpha. subunit (1995-08-01),

Title: Monica Van Der Vieren: Innovator in Monoclonal Antibodies

Introduction

Monica Van Der Vieren is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 10 patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Among her latest patents is the invention of monoclonal antibodies specific for the integrin α-d subunit. This invention relates to antibodies that are immunospecific for α integrin and those that compete with these antibodies for α binding. Another notable patent involves methods of inhibiting locomotor damage following spinal cord injury using α D-specific antibodies. These methods aim to treat spinal cord injuries through the application of α monoclonal antibodies.

Career Highlights

Monica has worked with Icos Corporation, where she contributed to innovative research and development in biotechnology. Her expertise in monoclonal antibodies has positioned her as a key figure in her field.

Collaborations

Throughout her career, Monica has collaborated with notable individuals such as W Michael Gallatin and William M Gallatin. These collaborations have further enhanced her research and development efforts.

Conclusion

Monica Van Der Vieren's contributions to the field of monoclonal antibodies demonstrate her innovative spirit and dedication to advancing medical science. Her patents and collaborations reflect her significant impact on biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…